JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

NeoGenomics Inc

Geschlossen

5.82

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.64

Max

5.86

Schlüsselkennzahlen

By Trading Economics

Einkommen

-19M

-45M

Verkäufe

13M

181M

Gewinnspanne

-24.867

Angestellte

2,200

EBITDA

-41M

-48M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+51.37% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

4. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-99M

732M

Vorheriger Eröffnungskurs

5.82

Vorheriger Schlusskurs

5.82

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

NeoGenomics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Aug. 2025, 17:49 UTC

Wichtige Markttreiber

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11. Aug. 2025, 15:12 UTC

Wichtige Markttreiber

SharpLink Gaming Shares Rise After Direct Offering, Ether Purchases

11. Aug. 2025, 13:47 UTC

Wichtige Markttreiber

BitMine Immersion Technologies Shares Rise on Large Ethereum Holding

4. Aug. 2025, 16:50 UTC

Wichtige Markttreiber

Verb Technology Shares Double After Private Placement, Intent to Buy Cryptocurrency

31. Juli 2025, 20:58 UTC

Ergebnisse

Coinbase Global Misses on 2Q Revenue, Outlook

31. Juli 2025, 20:37 UTC

Ergebnisse

MicroStrategy Swings to 2Q Profit on Bitcoin Gains

11. Aug. 2025, 12:01 UTC

Akquisitionen, Fusionen, Übernahmen

Empery Digital Acquired Additional 17.51 BTC for $2M Since Aug 6 >EMPD

11. Aug. 2025, 12:01 UTC

Akquisitionen, Fusionen, Übernahmen

Empery Digital Announces Exploration of Borrowing Facility to Support Opportunistic Shr Repurchases Below Net Asset Value >EMPD

11. Aug. 2025, 09:22 UTC

Akquisitionen, Fusionen, Übernahmen

MicroStrategy, Coinbase, Other Crypto Stocks Rise. What's Behind the Rally. -- Barrons.com

11. Aug. 2025, 08:48 UTC

Market Talk

Bitcoin Hits 4-Week High as Demand Rises -- Market Talk

8. Aug. 2025, 08:06 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8. Aug. 2025, 08:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Aug. 2025, 08:06 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Aug. 2025, 08:06 UTC

Market Talk

Bitcoin Eases But Stays at High Level; Trump Adds Support to Crypto -- Market Talk

7. Aug. 2025, 07:26 UTC

Market Talk

Bitcoin Falls as Tariffs Come Into Force -- Market Talk

6. Aug. 2025, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

Parataxis Holdings: Combines Bitcoin Exposure, Proprietary Growth Opportunities, Accretive Yield Generation >SBXD

6. Aug. 2025, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

Parataxis Holdings: Once Proposed Transaction Is Closed, Combined Co Will Be Named Parataxis Holdings Inc. and Seek to Trade on NYSE Under the Symbol 'PRTX' >SBXD

6. Aug. 2025, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

Parataxis Holdings LLC: Entered Into a Definitive Business Combination Agreement With SilverBox Corp IV >SBXD

6. Aug. 2025, 14:31 UTC

Market Talk

Bitcoin Moves Can Be Unpredictable -- Market Talk

6. Aug. 2025, 07:14 UTC

Market Talk

Bitcoin in Period of Consolidation But Could Turn Higher -- Market Talk

5. Aug. 2025, 13:55 UTC

Market Talk

Bitcoin Is Being Treated as a Portfolio Diversifier -- Market Talk

5. Aug. 2025, 08:43 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

5. Aug. 2025, 08:43 UTC

Market Talk

Bitcoin Eases Amid Tariff Uncertainty -- Market Talk

4. Aug. 2025, 08:37 UTC

Market Talk

Bitcoin Recovers as U.S. Rate-Cut Bets Rise -- Market Talk

1. Aug. 2025, 22:31 UTC

Ergebnisse

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

1. Aug. 2025, 08:22 UTC

Market Talk

Bitcoin Falls to Three-Week Low After Tariff News, Ahead of U.S. Data -- Market Talk

31. Juli 2025, 21:26 UTC

Ergebnisse

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31. Juli 2025, 20:43 UTC

Ergebnisse

Riot Platforms 2Q Produced 1,426 Bitcoin, as Compared to 844 During the Same 3-Mo Period in 2024 >RIOT

31. Juli 2025, 20:43 UTC

Ergebnisse

Riot Platforms 2Q Rev $153M >RIOT

31. Juli 2025, 20:31 UTC

Ergebnisse

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

Peer-Vergleich

Kursveränderung

NeoGenomics Inc Prognose

Kursziel

By TipRanks

51.37% Vorteil

12-Monats-Prognose

Durchschnitt 8.81 USD  51.37%

Hoch 12 USD

Tief 5.5 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für NeoGenomics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

12 ratings

4

Buy

8

Halten

0

Sell

Technischer Score

By Trading Central

7.7 / 10.27Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.